Opthea (ASX:OPT) has announced a boost to its cash reserves, receiving a $15.9m research and development tax incentive from ...

GPO Access: Advanced discussions with major group purchasing organizations (GPOs), including private health systems and the Veterans Administration (VA), with favorable coverage decisions anticipated ...

In high- and standard-risk patients CAS and TCAR look good, but some worry about skill sets, learning curves, and ...

BioNTech has signed a definitive agreement to acquire Biotheus to obtain complete worldwide rights to BNT327/PM8002, a ...

But they were also very open about the highs and lows of living with Prunella's heartbreaking vascular dementia diagnosis. In ...